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Abstract
Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with various malignancies, including Burkitt’s
lymphoma and nasopharyngeal carcinoma. Like all herpesviruses, the EBV life cycle alternates between latency and lytic
replication. During latency, the viral genome is largely silenced by host-driven methylation of CpG motifs and, in the switch
to the lytic cycle, this epigenetic silencing is overturned. A key event is the activation of the viral BRLF1 gene by the
immediate-early protein Zta. Zta is a bZIP transcription factor that preferentially binds to specific response elements (ZREs)
in the BRLF1 promoter (Rp) when these elements are methylated. Zta’s ability to trigger lytic cycle activation is severely
compromised when a cysteine residue in its bZIP domain is mutated to serine (C189S), but the molecular basis for this effect
is unknown. Here we show that the C189S mutant is defective for activating Rp in a Burkitt’s lymphoma cell line. The mutant
is compromised both in vitro and in vivo for binding two methylated ZREs in Rp (ZRE2 and ZRE3), although the effect is
striking only for ZRE3. Molecular modeling of Zta bound to methylated ZRE3, together with biochemical data, indicate that
C189 directly contacts one of the two methyl cytosines within a specific CpG motif. The motif’s second methyl cytosine (on
the complementary DNA strand) is predicted to contact S186, a residue known to regulate methyl-ZRE recognition. Our
results suggest that C189 regulates the enhanced interaction of Zta with methylated DNA in overturning the epigenetic
control of viral latency. As C189 is conserved in many bZIP proteins, the selectivity of Zta for methylated DNA may be a
paradigm for a more general phenomenon.
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Introduction
Methylation of DNA is generally associated with inhibition of
gene expression. This is mediated in part by the association of
specific methyl-CpG binding proteins with methylated DNA,
leading to transcriptional silencing and chromatin remodeling [1],
and in part by the inability of some transcription factors to bind to
methylated DNA [2]. A notable exception is the bZIP transcrip-
tion factor Zta (also known as BZLF1, ZEBRA, Z), which displays
enhanced recognition for methylated DNA [3,4].
Zta is encoded by Epstein-Barr virus (EBV), a human herpes
virus that infects the majority of the world’s population. EBV
causes infectious mononucleosis and is linked to malignancies such
as endemic Burkitt’s lymphoma, nasopharyngeal carcinoma, and
Hodgkin’s disease [5]. EBV infects then establishes long-term
latency in B-lymphocytes [6,5]. During latency, the EBV genome
is heavily methylated and few viral genes are expressed. Disruption
of EBV latency is sporadic, characterized by expression of the
majority of the EBV gene complement, replication of the genome
and release of virus [7,8].
Zta is the first viral gene expressed during the switch to lytic
replication. As well as enhancing its own expression in a positive
feedback loop [9], Zta activates a second viral transcription factor,
Rta, encoded by BRLF1 [10]. Both Zta and Rta are essential for
viral replication and together promote expression of the remaining
viral lytic genes [11]. The BRLF1 promoter, referred to as Rp,
contains three Zta-response elements (ZREs), two of which (ZRE2
and ZRE3) include CpG motifs that are subject to methylation. A
pivotal study demonstrated that the interaction of Zta with ZRE2
and ZRE3 is enhanced by methylation [3], a phenomenon
believed critical for lytic cycle activation.
The basic region of Zta’s bZIP domain contains a cysteine
residue, C189, which regulates the redox-sensitivity of DNA-
binding activity [12]. Substituting this cysteine with serine
(ZtaC189S) is sufficient to prevent reactivation of EBV from
latency and EBV genome replication [13,12]. Here we explore the
molecular basis for the dramatic effects of this point mutation. We
demonstrate that C189 is critical for the activation of BRLF1
expression and for recognition of the methylated ZREs in Rp,
both in vivo and in vitro. A previous study had shown that the point
mutation S186A compromises Zta’s ability to bind both the
methylated and non-methylated forms of the ZREs within Rp [4].
We propose a model in which S186 and C189 contact the two
cytosine methyl groups of a specific CpG motif, which is conserved
between ZRE2 and ZRE3. The relevance of a regulatory role for
C189 in methylated DNA recognition by Zta is discussed.
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C189 in Zta is critical for its ability to activate BRLF1
We and others have previously shown that altering a single
cysteine residue within the DNA contact region of Zta (ZtaC189S)
impairs its ability to disrupt EBV latency [13,12]. Here we asked
whether ZtaC189S is competent to initiate one of the earliest
events in latency disruption, the transcriptional activation of
BRLF1 (Figure 1A). Expression vectors encoding Zta and
ZtaC189S were introduced into a Burkitt’s lymphoma derived
cell line, Raji, and subsequent transactivation of the endogenous
viral Rp was assessed (Figure 1B). Basal expression of BRLF1 is low
in the absence of Zta, but is enhanced 33-fold following Zta
expression. In contrast, expression of an equivalent amount of
ZtaC189S resulted in only 4-fold enhancement of BRLF1
expression. Therefore, ZtaC189S is severely compromised for its
ability to transactivate the BRLF1 gene in Raji cells.
C189 is not essential for the interaction of Zta with non-
methylated ZREs
To investigate the molecular basis for this defect, we compared
the ability of Zta and ZtaC189S to bind to the three ZREs present
in Rp (Figure 2). All three of the ZREs contribute to Rp activity
and are important for activation of the endogenous viral gene by
chemical stimuli [14], although ZRE1 appears to be dispensable
on a fully-methylated template [3]. Zta and ZtaC189S were
produced by coupled transcription and translation in vitro and their
ability to interact with each ZRE was assessed by EMSA (Figure 2).
As summarized in Figure 2F, the proteins were equally capable of
binding to non-methylated ZRE1 and ZRE2 but, in agreement
with previous reports for Zta [3,12], neither Zta not ZtaC189S
showed a detectable interaction with non-methylated ZRE3.
Thus, the reduced ability of ZtaC189S to transactivate BRLF1 is
not due to an inherent defect in binding to the ZREs.
Interaction of Zta with methylated ZREs relies on C189 in
vitro and in vivo
We next asked what effect methylation of ZRE2 and ZRE3 had
on binding by Zta and ZtaC189S (ZRE1 lacks a CpG motif and
hence is not subject to methylation). Note that methylation yields
four methyl-cytosines in ZRE3 (two on each strand) but only two
in ZRE2 (Figure 2). In line with previous reports, methylation of
ZRE3 converted it from a marginal to a strong binding site for Zta
and methylation of ZRE2 also enhanced binding (Figure 3 and
[3,12,4]). Importantly, the ability of ZtaC189S to bind meZRE3
was markedly reduced compared to that of wild-type Zta
(Figure 3). Binding of ZtaC189S to meZRE2 was only modestly
reduced, to approximately 75% compared to wild type. An
independent mutation of C189 to alanine (ZtaC189A) also
resulted in decreased binding to meZRE3, suggesting that the
decreased binding of the C189S mutant was due to loss of the
cysteine and not, for example, merely due to phosphorylation of
the newly introduced serine.
To substantiate the above findings, we used chromatin
precipitation to evaluate the binding of Zta and ZtaC189S to
the BRLF1 promoter in vivo. Cells (293-BZLF1-KO) that contain
an episomal EBV genome [11] were transfected with vectors
encoding either His-tagged Zta or ZtaC189S and equivalence of
Figure 1. Single amino acid in basic region of Zta blocks the ability to transactivate Rp in BL cells. A. Schematic diagram showing the
relationship between Zta expression and activation of the BRLF1 promoter. B. Expression vectors for Zta, ZtaC189S and the relevant ‘‘empty’’ vector
(pBABE) were introduced into Raji cells and their ability to activate the endogenous BRLF1 gene determined. 24 hours after transfection, RNA was
prepared, cDNA was synthesized then amplified using quantitative PCR with specific primers for the BRLF1 transcript and a housekeeping gene, L32.
Expression of BRLF1 mRNA, following normalization for expression of L32 is shown, relative to that seen following Zta transfection (100%). C.
Expression of Zta and ZtaC89S were determined by quantitative PCR and expressed relative to expression of Zta (100%).
doi:10.1371/journal.ppat.1000005.g001
Author Summary
c herpesviruses are characterized by their life-long
persistence in the infected host. This is due in part to
their ability to establish latency in infected cells. Epstein-
Barr virus (EBV) is almost ubiquitous within the human
population. The virus establishes latency in B-lymphocytes
and is thought to reactivate and undergo replication
following physiological stimuli that lead to B-cell activa-
tion. During latency the DNA genome of EBV is methyl-
ated, resulting in epigenetic control of viral gene
expression. A viral protein that is key to viral reactivation
and replication, Zta, is unique amongst transcription
factors in displaying enhanced binding to methylated
DNA sites. Here, we define the molecular interactions that
predispose Zta to interact with methylated binding sites
and we identify a mutant of Zta that has lost the
preference for methylated sites. This allows us to probe
the relevance of the recognition of methylated DNA for
the reactivation of EBV from latency and to suggest that
EBV has evolved a mechanism to allow it to specifically
recognize methylated DNA and overturn epigenetic
silencing of its genome imposed by the host.
Interaction of Viral Protein with Methylated DNA
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ZtaC189S-associated chromatin complexes were isolated and the
co-precipitated DNA was amplified using quantitative PCR with
primers spanning the ZREs within Rp (Figure 4). As expected
[12], ZRE sequences in the precipitated chromatin were clearly
enriched, whereas regions lying 59 and 39 of Rp were not. Fine
mapping of the chromatin complexes allowed us to differentiate
between binding to ZRE1, ZRE2 and ZRE3. Whereas Zta and
ZtaC189S bound equally well to ZRE1, the interaction between
ZtaC189S and ZRE2 was partly compromised (relative to wild-
type Zta) and its interaction with ZRE3 was completely
eliminated. As Rp is fully methylated in cells harboring EBV
[3], the in vivo chromatin association and the in vitro DNA-binding
analyses correlate well. Taken together, these data demonstrate a
critical role for C189 in the interaction of Zta with meZRE3 and,
to a lesser extent, meZRE2.
Methyl-cytosine residues in MeZRE3 required for
interaction with Zta
As the interaction of Zta with ZRE3 is methylation-dependent
and the site contains four methylated cytosine residues, we
explored the relevance of each methylation site (see Figure 5A for
numbering convention). A series of double-strand versions of
ZRE3 was generated, each containing a single methyl-cytosine,
and binding to Zta was assessed in a competition assay. Initial
validation of the assay revealed that whereas a 20-fold excess of
fully methylated ZRE3 competes efficiently for Zta binding, non-
methylated ZRE3 fails to compete, even at a 100-fold excess
(Figure 5B,C). Each singly methylated version of ZRE3 competed
for binding to some degree (Figure 5D–G) implying that all four
methyl groups contribute to the interaction with Zta. The order of
competition efficiency was methyl cytosine
19.methyl cytosi-
Figure 2. Zta and ZtaC189S interact with non-methylated Rp ZREs equivalently. A. Schematic diagram showing the location of ZREs 1–3 in
Rp. Transcription of this gene occurs in a leftwards direction with respect to the viral genome. The numbering relates to the type I EBV genome
accession number NC_007605. Asterixes mark the methylated Cytosine residues. B. Zta and Zta C189s were generated in an in vitro translation
system and fractionated on SDS-PAGE, together with a non-programmed translation reaction (IVT). C.–E. Equivalent amounts of the indicated
proteins were subject to EMSA analysis with the probes indicated above. A reaction with no added protein was also included, indicated probe. F. The
three ZREs associated with Rp are aligned and their areas of conservation indicated by boxes. The interactions of Zta and ZtaC189S with each site are
summarized.
doi:10.1371/journal.ppat.1000005.g002
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22.methyl cytosine
0$methyl cytosine
219. Thus, methylation
within the CpG motif that is common to both ZRE2 and ZRE3
gave stronger competition than within the motif uniquely present
in ZRE3.
Structural modeling rationalizes the methylation
dependence of ZRE3 binding
To better understand the above observations, we modeled the
structure of Zta’s DNA-binding domain bound to methylated
ZRE3 and compared it to the previously reported model of Zta-
bound meZRE2 [15]. In the following description, we designate
residues within the two Zta monomers and the corresponding
DNA half-sites as ‘‘Left’’ or ‘‘Right’’, and the two CpG motifs as
motifs 1 and 2, as summarized in Figures 6A and D. The modeled
ZRE2 and ZRE3 structures, both based on the crystal structure of
Zta bound to an AP-1 site, differ exclusively in the right half-site,
as the two ZREs are identical except at base pairs 1 and 2
(Figure 6A).
In the crystal structure, Zta makes base-specific contacts with
the AP-1 site via residues N182 and R190. N182 interacts
symmetrically with base pairs 62 while R190 makes asymmetric
contacts: R190
Left interacts with the central guanine base while
R190
Right contacts the DNA phosphate backbone. In the modeled
ZRE structures, the contacts mediated by R190 are conserved
whereas those by N182 are not – a direct consequence of the DNA
sequence difference. More specifically, the N182 contacts are
disrupted in the left half-site of ZRE2 (because ZRE2 diverges
from AP-1 at base pair –2) and in both half-sites of ZRE3
(divergent at base pairs 62). The additional disruption in the right
half-site likely explains why Zta binds more weakly to ZRE3 than
to ZRE2 ([3]; Figure 2D and E).
How does methylation of ZRE3 enhance Zta binding? The
mechanism previously postulated for ZRE2 is that methylation of
CpG motif 1 results in a direct contact between the cytosine
19
methyl group and S186
Left, enhancing affinity by stabilizing a
hydrogen bond network that involves S186
Left, N182
Left and the
CpG motif’s Guanosine
29 base ([15]; Figures 6C and 7A). The
same mechanism can be proposed for ZRE3, as ZRE2 and ZRE3
have identical left half-sites. Also predicted to contribute to
enhanced binding is a hydrophobic contact between C189
Left and
the cytosine
22 methyl group (Figure 7A,C). This interaction, not
previously described, is common to both the meZRE2- and
meZRE3-bound Zta models. Thus, S186
Left and C189
Left are
postulated to interact with CpG motif 1 so as to simultaneously
engage the two methyl groups, which are located on complemen-
tary DNA strands (Figure 7A). Such interactions are consistent
with the ability of ZRE3 singly methylated on cytosine
+19 or
cytosine
22 to compete with fully-methylated ZRE3 for Zta binding
(Figure 5).
The ZRE3 model also suggests how methylation of CpG motif 2
influences Zta binding. The cytosine
–19 aromatic ring is in a
cation-p interaction with the guanidino group of R190
Left
(Figure 6B and 7B) [16]. Methylation would enhance this
interaction by increasing the amount of negative charge in the
p-electron system (CH3- is an electron-donating substitutent) and
by introducing an additional van der Waals contact with the
arginine side chain. On the complementary strand, the Cyt
0
methyl group contacts both S186
Right and R190
Right. Although
R190
Right does not interact with a DNA base, S186
Right is within
hydrogen bond distance of the base-contacting residue N182
Right;
hence, methylation may indirectly influence interactions involving
base pair +2o r+3. Although the atomic details cannot reliably be
predicted, these probably differ from those previously postulated
for S186
Left and CpG motif 1, as the stereochemical environments
of S186 and N182 differ between the two half-sites. Nevertheless,
the prediction that Zta residues contact both methyl groups of
CpG motif 2 agrees with the ability of ZRE3 singly-methylated at
cytosine
219 or cytosine
0 to compete with fully methylated ZRE3,
albeit more weakly than when methylated within CpG motif 1
(Figure 5). Indeed, the observation that methylation on CpG
motifs 1 and 2 has a differential effect on Zta binding is consistent
with these motifs mediating non-equivalent interactions with Zta
residues, due to their asymmetry relative to the ZRE3 pseudodyad
(Figures 6D, 7A and 7B).
Thiol/methyl-group contacts can explain the decreased
ZRE binding affinity of the ZtaC189S mutant
Our modelling predicts that C189
Left (marked by an asterisk in
Figures 6 and 7) is sensitive to the methylation state of CpG motif
1 via a direct contact involving the residue’s thiol group and the
cytosine
22 methyl group (Figure 7C). This interaction is favored
by the hydrophobic nature of the cysteine side chain [17].
Mutation to the more polar serine residue would destabilize this
contact by unfavorably juxtaposing the serine hydroxyl and Cyt
22
methyl groups. This agrees with the decreased binding affinity
observed for ZtaC189S toward both meZRE2 and meZRE3
(Figure 3). Moreover, the absence of this thiol-methyl contact in
Figure 3. ZtaC189S binding to meZREs in Rp is compromised in
vitro.A .EMSA analysis was undertaken for meZRE2 with the indicated
proteins or an unprogrammed lysate (IVT). B. Zta, ZtaC189A and
ZtaC189S were generated in vitro and analyzed by SDS-PAGE. C. EMSA
analysis of equivalent amounts of the indicated proteins was
undertaken with meZRE3 as described above.
doi:10.1371/journal.ppat.1000005.g003
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little effect on the binding to non-methylated ZRE2 (Figure 2D). A
possible alternative explanation, that an altered S186 or R190
conformation causes the decreased affinity, appears unlikely given
that C189 contacts neither residue (see, for example, Fig. 6C).
In contrast to C189
Left, C189
Right is too far from any cytosine
methyl group to form a direct contact (Figure 6B,C). However, in
the ZRE3 model, C189
Right is in van der Waals contact with the
thymidine
229 methyl group (Figure 7D). This interaction is
symmetrically equivalent to that of C189
Left with the cytosine
22
methyl group and consequently should also be destabilized by the
C189S mutation (Figure 6D). The interaction is unique to ZRE3,
as the corresponding base in ZRE2 is guanine
229, which lacks a
methyl group. Thus, the prediction is that the C189S mutation
destabilizes contacts in both half-sites of meZRE3, but in only one
of ZRE2. This agrees neatly with the finding that the mutation
more severely impairs Zta binding to meZRE3 than to meZRE2
(Figure 3).
Evidence for a direct contact between C189 and methyl
cytosine
22
Our modelling predicts that C189 directly contacts the
cytosine
22 methyl group within CpG motif 1, which is common
to ZRE2 and ZRE3. This complements a previous prediction that
S186 contacts the cytosine
19 methyl group in the same CpG motif
[15] (Figure 8A). We tested our hypothesis by assessing the ability
of Zta to bind versions of meZRE2 that omit methylation of either
the 19 or 22 cytosine residues. As predicted, omitting either
methyl group significantly reduces binding to each (the binding is
not entirely abolished, as Zta binds non-methylated ZRE2 with
appreciable affinity) (Figure 8B). We next investigated the
contribution of the cytosine
22 methyl group to the binding affinity
of the S186A and C189S point mutants. Our model predicts that
omitting this group should more significantly compromise the
binding affinity (relative to wild type) of the S186A mutant over that
of the C189S mutant, because only the former conserves the
cysteine thiol group. As shown in Figure 8C, ZtaS186A binds more
weakly to meZRE2 than does wild type Zta, in agreement with
previous studies [4]; omitting the cytosine
22 methyl group further
decreases the relative binding affinity, consistent with the loss of an
important contact. This is in stark contrast with the results observed
for ZtaC189S: although the relative affinity of this mutant toward
meZRE3 is weak, it is not significantly further reduced upon
omitting the cytosine
22 methyl group (Figure 8D). On the contrary,
binding is comparable to that of the wild type, which is dramatically
reduced compared to binding to the fully methylated ZRE3; the
methyl group of cytosine
22 enhances the DNA binding affinity of
wild type Zta to a greater extent than that of the C189S mutant.
The combined results strongly support the hypothesis that C189
directly contacts the cytosine
22 methyl group.
Discussion
Zta is the only known example of a transcription factor whose
binding to specific DNA sequence elements is enhanced by CpG
methylation [3]. In other contexts, the distinction between
methylated and unmethylated DNA is primarily orchestrated by
proteins lacking specific DNA-binding activity, such as the methyl
binding proteins MeCP2, MDB1, MDB2, MDB4 and Kaiso
[1,18]. A previous study demonstrated that mutations of S186
Figure 4. ZtaC189S binding to meZREs in Rp is compromised in vivo. A. Schematic representation of the BRLF1 gene. The black arrow
indicates the primary transcript. The location of primer sets used to detect sub-regions of Rp and upstream and downstream regions are indicated
relative to the transcription start site. B. HisZta and HisZtaC189S were introduced into 293-BZLF1-KO cells and chromatin prepared. Chromatin affinity
purification was undertaken and binding to Rp detected with the indicated primer sets by real-time PCR. The signal was set relative to the ‘‘empty
vector’’, pcDNA3 (striped box), and the signal for Zta (filled box) and ZtaC189S (open box) are shown together with the standard error from duplicate
experiments. C. Expression of HisZta, HisZtaC189S and a loading control, PARP, were assessed by western blot analysis.
doi:10.1371/journal.ppat.1000005.g004
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ZRE3 [4]. However, these mutations also alter interactions with
non-methylated ZRE2 and ZRE3 and compromise ZRE1
recognition. In contrast, the C189S mutant is compromised for
binding methylated ZRE3, and to a lesser extent ZRE2, but
retains wild type affinity towards many unmethylated sites,
including ZRE1 (Figures 2 and 3). Thus, the C189S mutant
provides a highly selective tool to address the relevance of
methylated ZRE recognition for the disruption of latency in vivo.
Consequently, our results strongly corroborate the hypothesis that
Zta binding to methylated ZREs is essential for the reactivation of
latent EBV in B-lymphocytes. More specifically, because
ZtaC189S is severely compromised for meZRE3 (but not
meZRE2) binding, the inability of this mutant to activate BRLF1
expression in Raji cells suggests that meZRE3 recognition is
particularly critical for Rp activation in this cell line (Figure 1).
Our present findings are in apparent disagreement with a
previous study showing that the ZtaC189S mutant is only
marginally compromised in reactivating BRLF1 expression [12].
The previous results, which we have verified (data not shown),
were obtained using EBV-positive 293 cells (BZLF1-KO-293), an
epithelial cell line. In contrast, we observe defective Rp activation
in Raji cells, which derive from a Burkitt’s lymphoma cell line.
EBV infects and replicates in both B-lymphocytes and epithelial
Figure 5. All four methylation sites on ZRE3 contribute to the binding by Zta. A. Schematic representation of the four methyl-cytosine
residues in ZRE3. Methylation is indicated by an asterisk and the numbering system is shown. B, C. Competition EMSA reactions were undertaken
with a labeled ZRE (ZIIIB) and non-labeled Zta protein. As indicated, increasing amounts (66,1 0 6,2 0 6,5 0 6,7 5 6and 1006excess) of unlabelled
competitor ZRE3 DNA (methylated or not) was included in the EMSA reaction. D–G. EMSA competition from replicate experiments showing the
ability of the indicated excess of each singly methylated ZRE3 site to compete for the binding of Zta. Experiments were undertaken in duplicate and
were used to calculate the standard deviation shown in the error bars.
doi:10.1371/journal.ppat.1000005.g005
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predominantly associated with B-lymphocytes making our findings
particularly relevant to understanding how Zta activates Rp in a
physiological setting. We speculate that the difference in Zta
behavior in B-lymphocytes and epithelial cells may partly reflect
differences in the milieu of cellular transcription factors or in
chromatin structure. Indeed, a recent study showed that,
compared to Raji cells, the level of ZRE2 methylation is slightly
lower in BZLF1-ZKO-293 cells, and substantially lower in another
epithelial cell line (AGS cells) [4]. Further studies are required to
establish whether and how EBV lytic activation is regulated in a
cell-specific manner.
Our structural model of Zta bound to meZRE3 reasonably
accounts for a number of experimental observations. In particular,
the model rationalizes why the binding affinity of Zta for
unmethylated ZRE3 is lower than for ZRE2, why methylation
increases the binding affinity for both sites, why the C189S
mutation compromises methyl-ZRE recognition, and why the
latter effect is more pronounced for ZRE3 than for ZRE2.
Furthermore, the model suggests that Zta residues contact all four
methyl groups in ZRE3’s two CpG motifs (Figure 7), consistent
with interactions observed for all four singly-methylated ZRE3
variants in a DNA-binding competition experiment (Figure 5).
Although unable to explain why methylation within CpG motif 1
yields stronger binding than within motif 2, the model is
nevertheless consistent with a differential effect, as it predicts
different stereochemical environments for the two motifs.
A key prediction resulting from the model is that a specific C189
residue in the Zta homodimer is sensitive to methylation of the
CpG motif common to ZRE2 and ZRE3 by means of a thiol-
methyl group contact (Figure 7C). This contact is lost or
destabilized by the replacement of C189 by A or S, consistent
with the decreased DNA-binding affinity observed for these
mutants (Figure 3). In contrast, the homodimer’s second C189
Figure 6. Structural model of Zta bound to meZRE3. A. Alignment of Zta recognition sequences. The numbering convention is shown for base
pair positions (bold italics) and individual nucleotides (plain font). Cytosines modified by methylation are indicated by a dot. B. Model of the Zta-
meZRE3 complex viewed along the pseudodyad. The methylation sensitive C189 residue (red asterisk) and bidentate hydrogen bond interactions
between R190
Left and Guanine
09 (dotted black lines) are indicated. Cytosine methyl groups are semi-transparent. C. Orthogonal view. The
hydrophobic contact between Cytosine
19 and S186
Left (broken blue line) and hydrogen bond network involving S186
Left, N182
Left and Guanine29
(dotted black lines) are shown. D. Schematic summary of contacts. van der Waals contacts involving the CpG methyl groups and Zta residues are
shown as broken lines.
doi:10.1371/journal.ppat.1000005.g006
Interaction of Viral Protein with Methylated DNA
PLoS Pathogens | www.plospathogens.org 7 2008 | Volume 4 | Issue 3 | e1000005residue is predicted to be remote from a CpG motif. In the case of
ZRE3, this residue can form a thiol-methyl group contact with a
thymine base (Figure 7D). The stability of the latter contact is
predicted to be susceptible to the C189S mutation regardless of
CpG methylation status. However, the decreased affinity of this
mutant can only be observed when the binding to methylated
ZRE3 is assessed, as the affinity of wild type Zta for unmethylated
ZRE3 is too low to appreciate any further decrease. C189 is
implicated in the redox sensitivity of Zta’s DNA binding activity,
and nitrosylation of this residue has been evoked as one possible
mechanism by which nitric oxide down-regulates EBV reactiva-
tion [12]. Our results concerning C189 suggest how such
regulatory phenomena might potentially be linked to methyl-
ZRE recognition and Rp activation.
Our current working model is that S186 and C189 interact with
both methyl-cytosines of a specific CpG motif to enhance the
bindingof Zta to a methylated ZRE, thereby overturning epigenetic
silencing of the viral genome. Such methylation-enhanced affinity is
conceivably unique to Zta, as no other bZIP proteins are known to
possesa serineresidueequivalent to S186.On theotherhand,C189
is relatively conserved among bZIP proteins: in a sequence
alignment of 50 human bZIP proteins, over half conserve this
residue, including c-Fos and c-Jun. It is therefore tempting to
speculate that CpG methylation may enhance the affinity of certain
cellular bZIP proteins for their cognate DNA target sites. This
tantalizing potential for Zta’s cellular homologs to overturn the
epigenetic silencing of genes awaits further investigation.
Materials and Methods
Cell culture
293-BZLF1-KO cells [11] and Raji cells were maintained as
described previously [13,12].
Transfection
Raji cells were transfected as described previously [13,19]. The
sequences of the primers used in determining BRLF1 gene
expression are as follows:
59-CAGAAAGTCTTCCAAGCCATCC and 59-CAAACA-
GACGCAGCCATGA.
Figure 7. Interactions mediated by the CpG motifs and C189 and S186 residues. A, B. Interactions involving the CpG motifs. Hydrophobic
contacts and hydrogen bonds are shown as dashed blue and dotted black lines, respectively. The two motifs are shown in roughly the same
orientation. CpG motif 1 interacts exclusively with the Left helix, whereas CpG motif 2 interacts with both bZIP helices. C, D. Thiol-methyl group
contacts mediated by C189 residues. Only C189
Left (asterisk) can sense CpG methylation status.
doi:10.1371/journal.ppat.1000005.g007
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Plasmids
Expression vectors encoding histidine tagged Zta and ZtaC189S
were generated by amplifying the coding sequence with the
following oligonucleotides, which incorporate a hexa-histidine
repeat at the amino terminus and sub-cloned into pcDNA3
(Invitrogen) using BamH1 and EcoR1.
59CTGCACACCGGGGATCCATGCATCATCATCATCA
TCATATGATGGACCCAAACTCGACTTCT and 59CTGC
ACACCGGGGAATTCTTAGAAATTTAAGAGATCCTCGT
GTAA
Zta, ZtaC189A, ZtaS186A were generated by site directed
mutagenesis.
Chromatin precipitation
Chromatin was prepared from 293-BZLF1-KO cells 48 hours
post transfection [20]. His-tagged protein complexes were isolated
on HIS-Select Nickel Affinity Gel slurry (Sigma-Aldrich). Primers
adjacent to each ZRE were used to amplify the sites.
ZRE1F (cggctgacatggattactgg);
ZRE1R (tgatgcagagtcgcctaatg);
ZRE2F (cagcagagaggctcggtt);
ZRE2R (tgcaatatttcctccagaaa);
ZRE3f (ggacaagatgtcactcttt);
zre3r (gggaagaaagtatagctac);
Rta39F (TCCCTGTATTCACTGAGCGTCG);
Rta39R (GGTCCCTTTGCAGCCAATGC);
Rta 59F (CTTCGGGATAGTGTTTCAGG);
Rta 59R (CTCAGCCCGTCTTCTTACC).
EMSA
Radio labeled probes were generated with [
33P] or [
32P] and
analyzed as described previously [21,22,13,19]. In vitro translated
proteins were generated in a rabbit reticulocyte lysate system or a
wheat germ translation system, radio labeled with [
35S] methio-
nine. Competition EMSA was undertaken using unlabeled Zta
protein and a radio labeled Zta binding site (ZIIIB).
The 59 oligonucleotide sequences of the ZRE1, 2 and 3 probes
(Invitrogen) and their methylated versions, with methyl-cytosine
marked as O, (Sigma) are as follows:
ZRE1:59-GATCTCTTTTATGAGCCATTGGCA-39
ZRE2:59-GATCATAAAATCGCTCATAAGCTT-39
ZRE3:59-GATCTATAGCATCGCGAATTTTGA-39
ZRE2-meth:59-GATCATAAAATOGCTCATAAGCTT-39
ZRE3-meth:59-GATCTATAGCATOGOGAATTTTGA-39
D19 or D-2 versions of the methylated primers were also
synthesized (Sigma).
Molecular modeling
The crystal structure of Zta bound to a 19-mer DNA duplex
containing an AP-1 site (PDB accession id 2C9L) was used to
model Zta bound to a methylated ZRE3 site. Base-pair
replacements converting an AP-1 sequence to that of ZRE3 (see
Figure 4A) were made in program O [23], with bases set to adopt
ideal Watson-Crick base-pairing and the template DNA backbone
kept fixed. Methylation at a given C:G base pair position was
modeled by least-squares superposition of a m
5C:G base pair taken
from the crystal structure of the self-complementary DNA duplex
CCAGGC(m
5C)TGG [24]; PDB accession id 2D25. Figures 6 and
7 were prepared using Bobscript [25] and Raster3d [26].
Accession numbers
EBV genome used type 1 NC_007605; Zta (BZLF1) swiss prot
P03206; Burkitt’s lymphoma OMIM # 113970.
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